Susquehanna International Group, LLP Abeona Therapeutics Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024
SELL
$3.17 - $8.05 $35,504 - $90,160
-11,200 Reduced 29.09%
27,300 $115,000
Q1 2024

May 07, 2024
BUY
$4.07 - $8.68 $31,746 - $67,704
7,800 Added 25.41%
38,500 $279,000
Q4 2023

Feb 14, 2024
BUY
$3.71 - $5.14 $46,004 - $63,735
12,400 Added 67.76%
30,700 $153,000
Q3 2023

Nov 14, 2023
BUY
$2.98 - $4.43 $54,534 - $81,069
18,300 New
18,300 $77,000

Others Institutions Holding ABEO

# of Institutions
57
Shares Held
28.4M
Call Options Held
827K
Put Options Held
44.5K
View Full List

About ABEONA THERAPEUTICS INC.

ABEO Quotes by TradingView
  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $35M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email